Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 8/20 | 0.56 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL501671 | 0.88 | SLC9A1 (0.67) | SLC9A1GRM2RAB9ANPC1MEN1 | |
| SCHEMBL31066857 | 0.88 | SLC9A1 (0.67) | SLC9A1GRM2RAB9ANPC1MEN1 | |
| SCHEMBL31667053 | 0.84 | SLC9A1 (0.54) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL29479886 | 0.79 | SLC9A1 (0.65) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL5017651 | 0.79 | SLC9A1 (0.59) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL12001037 | 0.79 | SLC9A1 (0.59) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL2488643 | 0.79 | SLC9A1 (0.65) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL3463660 | 0.76 | SLC9A1 (0.57) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL14796568 | 0.76 | SLC9A1 (0.79) | SLC9A1GRM2RAB9ANPC1MAPT | |
| SCHEMBL31234269 | 0.75 | SLC9A1 (0.70) | SLC9A1GRM2RAB9ANPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120008228-A1 | MAGNETIC RECORDING MEDIA AND MAGNETIC RECORDING SYSTEM | HITACHI, LTD. | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120008228-A1 | MAGNETIC RECORDING MEDIA AND MAGNETIC RECORDING SYSTEM | NCS1, CA1, GRIN2A | SLC9A1 477/4885GRM2 68/4885RAB9A 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.